Go Back

Appropriate Use of FDG-PET

The purpose of this publication is to develop a consensus based on evidence from existing systematic reviews, to make health care providers aware of the value and the appropriateness of the introduction of positron emission tomography (PET), either alone or in combination with computed tomography (PET/CT) using 2-fluoro-2-deoxy-D-glucose (FDG) labelled with 18F, in the management of patient affected by cancer.